Stage 0 Pancreatic Cancer AJCC v8 Recruiting Phase 2 Trials for Calcium (DB01373)
Indication | Status | Phase |
---|---|---|
DBCOND0121165 (Stage 0 Pancreatic Cancer AJCC v8) | Recruiting | 2 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT04539808 | NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer | Treatment |